Powered by

Surmodics Reports Fourth Quarter Fiscal 2020 Results

Nov 04, 2020 - Nasdaq
Financial Results

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2020 fourth quarter ended September 30, 2020.

Summary of Fourth Quarter and Recent Highlights

Revenue of $22.5 million, a decrease of 27% year-over-year GAAP EPS of ($0.22), non-GAAP EPS of ($0.18) FDA clearance received for PounceTM Thrombus Retrieval System for non-surgic...